<DOC>
	<DOC>NCT00144898</DOC>
	<brief_summary>Sentinel node resection appears as a promising advancement in the surgical treatment of breast cancer. The GF-GS 01 study, sponsored by a National Hospital Research Program, compares this new surgical method with a classical method in patients having a negative sentinel node. The duration of the follow-up is 5 years.</brief_summary>
	<brief_title>GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women older than 18 years with clinically nodenegative operable unifocal N0 breast cancer (clinical tumour size &lt; 30 mm). Written consent is obtained from all patients before randomization.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>sentinel node resection</keyword>
	<keyword>survival</keyword>
	<keyword>Breast cancer unifocal N0</keyword>
</DOC>